News Category
Get MRI Now has expanded its no-referral MRI authorization platform from Florida into nine additional states, covering over 140 million Americans and ...
Nano-X Imaging's Q1 2026 revenue growth and FDA-cleared AI solutions underscore its strategic push into preventive healthcare through an end-to-end im...
Vinmec Healthcare System launches a nationwide multi-connected robotic surgery ecosystem, integrating advanced robotic platforms across specialties an...
HeartBeam (NASDAQ: BEAT) announced a strategic reorganization to accelerate commercialization of its 3D ECG platform, expand global partnerships, and ...
HeartBeam's new pilot study tests its proprietary patch that can generate on-demand 12-lead ECGs, potentially revolutionizing ischemia detection in am...
The global accelerometer medical sensors market is projected to grow from USD 7.0 billion in 2026 to USD 25.7 billion by 2036 at a CAGR of 13.9%, driv...
A meta-analysis published in the Journal of the American Heart Association reveals that smartphone apps and wearable fitness trackers help people with...
SS Innovations completed a record-breaking robotic cardiac telesurgery across 12,500 miles, demonstrating the global reach of its SSi Mantra system an...
A peer-reviewed study published in JACC: Advances found that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can ...
Advances in artificial intelligence and edge computing are transforming healthcare wearables from data collectors into clinical tools that provide rea...
A peer-reviewed study in JACC: Advances shows that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately...
LataMed AI Corp. will attend MEDICA 2026 in Germany as part of its strategy to evaluate healthcare technologies and build a scalable telehealth platfo...
HeartBeam is developing a portable, cable-free ECG platform that generates synthesized 12-lead signals from multidirectional recordings, aiming to add...
A small study published in Circulation: Arrhythmia and Electrophysiology found that a smart wristband using photoplethysmography accurately detected c...
The American Heart Association, with support from T-Mobile, is launching a national initiative to identify and address communication and technology ga...
LogicMark's evolving suite of AI-driven personal emergency response systems and connected care platform aims to shift senior safety from reactive to p...
HeartBeam (NASDAQ: BEAT) announced first-quarter 2026 financial results, highlighting initial commercial partnerships, progress in heart attack detect...
MindBio Therapeutics Corp. is featured in a BioMedWire editorial discussing its AI voice analysis platform that detects impairment from brief speech r...
SS Innovations successfully performed a long-distance telesurgery from Australia to India using its SSi Mantra surgical robotic system, demonstrating ...
MindBio Therapeutics Corp. introduces AI-powered fatigue recognition technology that analyzes voice patterns, set to be added to its Edge AI Kiosks fo...
MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication in real time, targeting workplace safe...
MindBio Therapeutics uses AI and voice analysis to detect drug and alcohol intoxication from short speech samples, offering a noninvasive, real-time a...
Aclarion issued an inducement stock option to its newly hired Commercial Director for the Western U.S., Daniel Keefe, reflecting the company's expansi...
HeartBeam Inc. is developing advanced ECG solutions to address patient delays in seeking cardiac care and improve early detection of cardiovascular di...
Ventripoint will exhibit at the 59th AEPC meeting in Padua, Italy, demonstrating its VMS+™ 4.0 system that provides MRI-equivalent volumetric cardiac ...
Aclarion's Q1 2026 results show 196% year-over-year scan volume growth, driven by increasing physician adoption and reimbursement progress, positionin...
Ventripoint Diagnostics announced that its strategic partner Lishman Global has submitted the VMS+ 4.0 system to China's NMPA for regulatory approval,...
Aclarion appoints Daniel Keefe as Commercial Director for the Western U.S. to drive adoption of its Nociscan platform, which uses AI to identify pain-...
HeartBeam Inc. partners with Mount Sinai to advance AI-driven ECG technology for improved cardiac monitoring and chronic condition management.
Cardio Diagnostics Holdings (NASDAQ: CDIO) is leveraging artificial intelligence to integrate multi-omic data from a simple blood draw, providing pers...
HeartBeam Inc. partners with Mount Sinai to develop and validate AI-based ECG algorithms for remote cardiac monitoring, highlighting the shift toward ...
SS Innovations International, Inc. revealed several surgical robotic systems under development at the Global Multi-Specialty Robotic Surgery Conferenc...
Cardio Diagnostics Holdings leverages AI, epigenetics, and genetics to transform cardiovascular disease prevention, detection, and management, offerin...
HeartBeam (BEAT) completed a $10 million public offering to fund commercialization of its FDA-cleared 12-lead synthesized ECG system and expand AI cap...
Cardio Diagnostics Holdings is highlighted as a company to watch for its AI-driven approach to cardiovascular disease prevention, detection, and manag...
HeartBeam Inc. closed a $10 million public offering to fund the commercialization of its FDA-cleared 12-lead synthesized ECG system and advance its ex...
Aclarion announced a new U.S. patent covering AI-driven analysis of MRS data for chronic low back pain, expanding its IP portfolio to 64 patents and s...
Aclarion's Nociscan platform, which uses AI to analyze biomarkers for discogenic pain, receives a Diamond Pinnacle Award, marking key validation for i...
Catalyst Crew Technologies Corp. announced the development of PulmoAI, an AI-powered module for detecting and predicting pulmonary diseases, aiming to...
Aclarion announces nearly 100 Nociscan procedures performed at The London Clinic, featuring a physician video discussing the tool's role in evaluating...
TibaRay opens its Regulation CF campaign on Wefunder, allowing individual investors to support its next-generation accelerator technology designed to ...
HeartBeam Inc. received an analyst upgrade and price target increase from Joseph Gunnar & Co. following FDA clearance of its 12-lead ECG synthesis sof...
Sigyn Therapeutics' CardioDialysis device integrates plasma separation and therapeutic adsorption within a single unit deployable on standard dialysis...
HeartBeam announced a collaboration with Mount Sinai to develop and validate AI-based ECG algorithms for personalized cardiac monitoring, enhancing it...
NextPlat Corp. announced its full-year 2025 earnings release and conference call on March 31, 2026, providing investors with key financial results and...
Catalyst Crew Technologies Corp. has submitted a corporate action request to FINRA to change its name to LataMed AI Corp. and its trading symbol, alig...
Aclarion announced a one-year stockholder rights plan to prevent hostile takeovers and ensure all shareholders receive fair value, reflecting the boar...
Aclarion's CEO shareholder letter outlines key 2026 catalysts including pursuing U.S. regional insurance reimbursement, an initial CLARITY trial reado...
